Van der Bent A - Search Results

1

Molecular modelling of asperlicin derived cholecystokinin A receptor antagonists.

Van der Bent A, Ter Laak AM, IJzerman AP, Soudijn W. Van der Bent A, et al. Eur J Pharmacol. 1992 Aug 3;226(4):327-34. doi: 10.1016/0922-4106(92)90050-6. Eur J Pharmacol. 1992. PMID: 1397061

2

Hybrid cholecystokinin-A antagonists based on molecular modeling of lorglumide and L-364,718.

van der Bent A, Blommaert AG, Melman CT, IJzerman AP, van Wijngaarden I, Soudijn W. van der Bent A, et al. Among authors: van wijngaarden i. J Med Chem. 1992 Mar 20;35(6):1042-9. doi: 10.1021/jm00084a009. J Med Chem. 1992. PMID: 1552499

3

Molecular modelling of CCK-A receptors.

Van Der Bent A, Ijzerman AP, Soudijn W. Van Der Bent A, et al. Drug Des Discov. 1994 Nov;12(2):129-48. Drug Des Discov. 1994. PMID: 9116168

4

Absolute conservation of residue 6 of immunoglobulin heavy chain variable regions of class IIA is required for correct folding.

de Haard HJ, Kazemier B, van der Bent A, Oudshoorn P, Boender P, van Gemen B, Arends JW, Hoogenboom HR. de Haard HJ, et al. Among authors: van der bent a, van gemen b. Protein Eng. 1998 Dec;11(12):1267-76. doi: 10.1093/protein/11.12.1267. Protein Eng. 1998. PMID: 9930677

5

Vernier zone residue 4 of mouse subgroup II kappa light chains is a critical determinant for antigen recognition.

de Haard H, Kazemier B, van der Bent A, Oudshoorn P, Boender P, Arends JW, van Gemen B. de Haard H, et al. Among authors: van der bent a, van gemen b. Immunotechnology. 1999 Mar;4(3-4):203-15. doi: 10.1016/s1380-2933(98)00021-9. Immunotechnology. 1999. PMID: 10231090

6

Clavanin permeabilizes target membranes via two distinctly different pH-dependent mechanisms.

van Kan EJ, Demel RA, Breukink E, van der Bent A, de Kruijff B. van Kan EJ, et al. Among authors: van der bent a. Biochemistry. 2002 Jun 18;41(24):7529-39. doi: 10.1021/bi012162t. Biochemistry. 2002. PMID: 12056883

7

The role of the abundant phenylalanines in the mode of action of the antimicrobial peptide clavanin.

van Kan EJ, Demel RA, van der Bent A, de Kruijff B. van Kan EJ, et al. Among authors: van der bent a. Biochim Biophys Acta. 2003 Sep 2;1615(1-2):84-92. doi: 10.1016/s0005-2736(03)00233-5. Biochim Biophys Acta. 2003. PMID: 12948590 Free article.

8

The peptide antibiotic clavanin A interacts strongly and specifically with lipid bilayers.

van Kan EJ, Ganchev DN, Snel MM, Chupin V, van der Bent A, de Kruijff B. van Kan EJ, et al. Among authors: van der bent a. Biochemistry. 2003 Sep 30;42(38):11366-72. doi: 10.1021/bi0349017. Biochemistry. 2003. PMID: 14503887

9

Membrane activity of the peptide antibiotic clavanin and the importance of its glycine residues.

van Kan EJ, van der Bent A, Demel RA, de Kruijff B. van Kan EJ, et al. Among authors: van der bent a. Biochemistry. 2001 May 29;40(21):6398-405. doi: 10.1021/bi0028136. Biochemistry. 2001. PMID: 11371202

10

Interaction of beta-lactoglobulin with small hydrophobic ligands as monitored by fluorometry and equilibrium dialysis: nonlinear quenching effects related to protein--protein association.

Muresan S, van der Bent A, de Wolf FA. Muresan S, et al. Among authors: van der bent a. J Agric Food Chem. 2001 May;49(5):2609-18. doi: 10.1021/jf0012188. J Agric Food Chem. 2001. PMID: 11368643

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

15 results

Search Page

Filters